Similar with a previous study in AKI, our data also found low expression of renal QPRT, QA accumulation, and low NAD+ levels in CKD models, which suggested that de novo NAD + synthesis was impaired in CKD and may represent therapeutic target for CKD treatment. This evidence concerns the gene QPRT and chronic kidney disease.